Encoded's gene therapy reduced seizures in Dravet syndrome

Encoded Therapeutics has developed a gene therapy that significantly reduced seizures by 76% in children suffering from Dravet syndrome, a severe neurodevelopmental disorder. This promising result was noted in a small cohort of three patients who received the treatment, highlighting the potential of gene therapy in addressing challenging medical conditions.